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Transcatheter shock ablation of ventricular tachycardia 
was attempted in seven patients who had drug-resistant 
ventricular tachycardia and in one patient in whom ven-
tricular tachycardia was electrophysiologically induced 
during therapy with multiple antiarrhythmic drugs. Seven 
patients had previous myocardial infarction and five of 
them were high risk candidates for surgical therapy. One 
patient without organic heart disease had repetitive ven-
tricular tachycardia manifesting two different patterns 
of left bundle branch block. After endocardial mapping, 
synchronized unipolar 250 to 300 J shocks (one to six) 
were delivered between the pole recording the earliest 
endocardial activity during ventricular tachycardia (40 
to 200 ms before the onset of the QRS complex) and a 
body surface electrode. Immediate complications in-
cluded severe but reversible cardiogenic shock (one pa-
tient), nonclinical ventricular tachycardia (two patients, 
requiring cardioversion in one), transient atrioventric-
ular and intraventricular conduction disturbances (three 
patients) and permanent left bundle branch block (one 
Patients with drug-refractory ventricular tachycardia are 
candidates for surgery, antitachycardia pacemakers or au-
tomatic defibrillators 0-3). Recently, delivery of localized 
direct current intracardiac shocks at the site of origin of 
ventricular tachycardia was shown to be effective in ablating 
foci of ventricular tachycardia (4). However, only a small 
number of patients undergoing this therapy have been re-
ported on (4-11). In the present study, we describe our 
initial experience with transcatheter shock ablation of ven-
tricular tachycardia in eight patients. 
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patient). A late complication in one patient, left heart 
failure, occurred 3 days after delivery of five intracar-
diac shocks. In two patients, left ventricular ejection 
fraction markedly decreased and in one of them new 
ventricular contraction abnormalities appeared. 
Clinical ventricular tachycardia did not recur in five 
of the seven post-myocardial infarction patients after 7 
to 17 months, and it was not inducible in the four patients 
undergoing late electrophysiologic study. In the patient 
with idiopathic ventricular tachycardia, one of the con-
figurational types of ventricular tachycardia recurred. 
It is concluded that transcatheter shock ablation of ven-
tricular tachycardia is a promising technique that war-
rants further investigation, especially in high risk sur-
gical candidates. The high incidence of complications, 
however, should temper any temptation to consider rou-
tine use of this procedure in patients with ventricular 
tachycardia. 
(J Am Coll CardioI1986;7:1347-55) 
Methods 
Patients. The study group comprised eight patients, seven 
men and one woman, ranging in age from 21 to 66 years 
(mean 49 ± 16) (Table 1). Seven patients had coronary 
heart disease and had had a myocardial infarction 3 weeks 
to 5 years before the present hospitalization. Two patients 
(Cases 3 and 5) had a localized left ventricular aneurysm. 
Left ventricular ejection fraction, as determined by radio-
nuclide ventriculography, ranged from 19 to 38% (mean 
28 ± 6). One patient (Case 7) showed no demonstrable 
heart disease on right and left ventriculography and coronary 
angiography. However, her left ventricular ejection fraction 
was slightly depressed (45%), probably because of the car-
diodepressive effect of concomitant therapy with 320 mg 
of propranolol and 120 mg of ajmaline bitartrate daily. 
All eight patients had symptomatic ventricular tachyar-
rhythmias (Table 1). Patient I had incessant ventricular 
tachycardia that could not be terminated by antiarrhythmic 
drugs, right and left ventricular pacing techniques or re-
peated external cardioversions. This patient has been de-
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Table 1. Clinical and Electrocardiographic Characteristic, of the Eight Study Patients 
Age (yr) Spontaneous Frequency of VT VT Cycle LVEF 
Case & Sex ArrhythmIa EpIsodes of ArrhythmIa ConfiguratIon Length (ms) ('tc ) 
44/M VT Incessant RBBB,LAD 360 30* 
2 65/M VT 3 In I month RBBB, LAD 300 26 
3 66/M VT 15 In 2 weeks LBBB,LAD 450 28 
4 55/M VT 4 in 10 months LBBB, LAD 460 19 
5 301M VTiVF I In 2 years 38 
6 60/M VTiVF 10 In 5 months RBBB, axis - 1500 450 26 
RBBB,RAD 430 
7 21/F VT RepetItive LBBB,RAD 280 45 
LBBB,NA 280 
8 53/M VT I in 2 months RBBB, LAD 400 27 
*Measured during ventncular tachycardIa. F = female; LAD = left aXIs deVIatIon; LBBB = left bundle branch block; LVEF = left ventricu-
lar ejection fraction; M = male; NA = nonnal axis; RAD = right aXIs devIatIon; RBBB = rIght bundle branch block, VF = ventrIcular fibrillation; 
VT = ventrIcular tachycardia 
scribed elsewhere (11). Patient 2 had multiple episodes of 
sustained ventricular tachycardia that could be terminated 
only temporarily by either right ventricular pacing or ex-
ternal cardioversion. Three patients (Cases 3, 4 and 8) had 
recurrent drug-resistant sustained ventricular tachycardia. 
Patients 5 and 6 had, respectively, single and multiple ep-
isodes of cardiac arrest, and rapid ventricular tachycar-
dia/ventricular fibrillation was documented at the time of 
resuscitation. In Patient 5, the arrhythmia was controlled 
by amiodarone therapy but neither amiodarone nor various 
antiarrhythmic agents prevented induction of rapid sustained 
monomorphic ventricular tachycardia by programmed ven-
tricular stimulation. In Patient 6, who had severe angina, 
the tachyarrhythmias frequently occurred during episodes 
of ischemia and were not prevented by antiarrhythmic or 
antianginal drugs. Patient 7 had drug-refractory repetitive 
ventricular tachycardia consisting mainly of short runs 
«30 seconds) and, less commonly, sustained episodes 
requiring pharmacologic intervention. 
Twelve lead electrocardiography during spontaneous 
ventricular tachycardia showed a single configuration in five 
patients (Cases 1 to 4 and 8) and two configurations in two 
patients (Cases 6 and 7). In Patient 5, a single electrocar-
diographic lead showed a pleomorphic ventricular tachy-
cardia. 
Five patients (Cases 1, 2, 4, 6 and 8) had poor left 
ventricular function and were considered high risk candi-
dates for surgical intervention. All patients gave written 
consent for electrophysiologic studies and ablative proce-
dures. 
Electrophysiologic studies. All patients underwent 
electrophysiologic studies, including programmed ventric-
ular stimulation and catheter endocardial mapping, using 
standard methods previously described (12). At the time of 
the studies, Patients 1 to 6 were receiving amiodarone alone, 
Patient 7 was receiving propanolol and ajmaline and Patient 
8 was not receiving any drug. Two quadripolar electrode 
catheters (USCI no. 6) were introduced through femoral 
veins and positioned in the right ventricular apex and the 
His bundle area. Another quadripolar electrode catheter (USCI 
no. 6. I cm interelectrode distance) was introduced into the 
left ventricle. In Patient 7, an additional electrode catheter 
was introduced into the right ventricle. 
In patients with no spontaneous ventricular tachycardia 
at the beginning of the electrophysiologic study. pro-
grammed stimulation from the right or left ventricular apex 
was performed to induce ventricular tachycardia. The stim-
ulation protocol included the delivery of one or two ex-
trastimuli during sinus rhythm or during ventricular pacing 
at cycle lengths of 700 to 400 ms using stimuli of 2 ms 
duration and 3 or 20 rnA intensity. 
The site of origin of ventricular tachycardia was deter-
mined by extensive endocardial mapping of the left ventricle 
in the seven patients with coronary heart disease and of the 
right ventricle in Patient 7, in whom a right ventricular origin 
of the tachycardia was suspected. Precise endocardial map-
ping was feasible. as spontaneous or pacing-induced ven-
tricular tachycardia was well tolerated hemodynamically in 
all eight patients. 
Electrocardiographic leads I, II, III and VI and intra-
cardiac electrograms were recorded on an eight channel 
Siemens-Elema Mingograph at paper speeds of 25 and 100 
mmfs. Twelve lead electrocardiograms were frequently re-
corded during induced ventricular tachycardia and compared 
with electrocardiographic tracings during spontaneous ven-
tricular tachycardia. A Medtronic 5325 stimulator was used 
for cardiac stimulation, Femoral artery pressure was con-
tinuously recorded throughout the procedure, Heparin (5,000 
U) was administered to all the patients, 
Definitions, The site of origin of ventricular tachycardia 
was arbitrarily defined as the earliest recorded endocardial 
electrical activity occurring in late diastole before the surface 
QRS complex during ventricular tachycardia (12), Induced 
ventricular tachycardia was defined as clinical when its con-
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figuration and rate were similar to those of the spontaneously 
observed tachycardia. Induced ventricular tachycardia was 
defined as nonclinical when its configuration was different 
from that of the spontaneously occurring ventricular tachy-
cardia. 
Transcatheter shock ablation. This procedure was per-
formed according to the technique previously described by 
Hartzler (4). Synchronous unipolar shocks were delivered 
using a standard defibrillator (Mennen-Greatbatch). The an-
odal output of the defibrillator was connected to a paddle 
placed at either the left posterolateral area or the anterior 
area (V 4 position) of the chest and the cathodal output was 
connected to the electrode recording the earliest endocardial 
activation during ventricular tachycardia. In Patient I, tech-
nical difficulties prevented the administration of the shocks 
at the area showing the earliest endocardial activity. and 
therefore shocks were delivered at an adjacent site showing 
less early activity ( II ). However, for the purpose of clarity, 
the latter site was referred to as the site of origin of ven-
tricular tachycardia. Except for the first two 250 1 shoch 
given to Patient I, all shocks delivered had an energy level 
of 300 1. 
Protocol. The number of shocks varied in each patient, 
depending on effects, increasing experience and ability to 
induce ventricular tachycardia after the shock. However, 
we attempted to conform to the following protocol in most 
of our patients. After completion of endocardial mapping 
of ventricular tachycardia, the patients were anesthetized 
with midazolam, a benzodiazepin derivative, until a state 
of deep sedation was achieved. Additional intravenous bol-
uses of midazolam were subsequently given throughout the 
procedure if necessary. The first intracardiac shock was 
delivered during ventricular tachycardia at its presumed site 
of origin. The intracardiac electrograms were continuously 
monitored before the shock to ascertain constant catheter 
position. After application of the shock, the patient was 
observed for 10 minutes. If ventricular tachycardia did not 
spontaneously recur during this period, induction by pro-
grammed ventricular stimulation was attempted. Whenever 
ventricular tachycardia could be induced, endocardial map-
ping of the tachycardia was again performed and a second 
intracardiac shock given as previously described. Five pa-
tients received a third shock. No patient received more than 
three shocks during a single procedure. In Patient 4, ven-
tricular tachycardia could not be induced after the first shock 
and a second shock was given during sinus rhythm at the 
site of the first shock. In patients in whom well tolerated 
nonclinical ventricular tachycardia occurred or was induced 
by programmed ventricular stimulation after a shock, en-
docardial mapping of this tachycardia was accomplished. If 
the site of origin of the tachycardia was found to be close 
to that of the clinical tachycardia, an intracardiac shock was 
given at this site. 
Four patients underwent two series of shocks within a 1 
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to 4- day period, and a single series of shocks was admin-
istered in the remaining four patients. At the end of the 
procedures, the patients were given a specific benzodiazepin 
receptor antagonist (RO 15-1788) that promptly restored 
consciousness. Both midazolam (13) and RO 15-1788 (Geller 
et al., unpublished data) have been shown to exert no sig-
nificant cardiovascular effects. 
Other procedures. After the catheter ablation proce-
dure, the patient was transferred to the coronary care unit. 
A 12 lead electrocardiogram was recorded every 12 hours 
for the first day after the ablative procedure and daily there-
after. A chest X-ray film was obtained immediately after 
the ablative procedure. Serum creatine kinase and the crea-
tine kinase-MB fraction were measured at 8 hour intervals 
for 3 days. In our laboratory, normal values for serum crea-
tine kinase are less than ISO IU, and the normal creatine 
kinase-MB fraction is less than 5%. In seven patients, a 
radionuclide ventriculogram (technetium-99 pyrophosphate) 
was performed before and 3 to 6 days after the ablative 
procedures. In our laboratory, normal values for left ven-
tricular ejection fraction are 50 ± 3%. In four patients 
electrophysiologic studies were performed 7 to 60 days after 
the ablative procedures. Programmed stimulation from the 
right ventricular apex, using the stimulation protocol de-
scribed, was used in each patient. 
Discharge antiarrhythmic regimen and follow-up. 
Patients I to 6, who were receiving amiodarone before the 
ablative procedures, were given the same drug after the 
procedure. Patients 7 and 8 were taking flecainide and no 
drug, respectively, when discharged. The patients were 
monitored by transtelephonic electrocardiographic monitor-
ing and underwent outpatient clinic examination every 2 
months. 
Results 
Pre-ablation electrophysiologic studies (Table 2). Of 
the seven patients with coronary heart disease (Cases I to 
6 and 8), clinical ventricular tachycardia could be induced 
by programmed ventricular stimulation from the right or left 
ventricular apex in six and occurred spontaneously in one 
(Case I). Endocardial mapping of clinical ventricular tachy-
cardia showed that the earliest endocardial activation was 
close to the infarcted area and preceded the onset of the 
QRS complex by 50 to 200 ms (Fig. I to 3). 
In Patient 7. who had no obvious heart disease. pro-
grammed atrial and ventricular stimulation failed to induce 
ventricular tachycardia. Mapping of one configurational type 
of spontaneously occurring ventricular tachycardia showed 
earliest endocardial activation in the high right ventricular 
septum, whereas mapping of ventricular premature com-
plexes that mimicked the second type of spontaneously oc-
curring tachycardia showed earliest activation in the right 
ventricular outflow tract. 
Table 2. Catheter Ablation Procedures in the Eight Study Patients c...> 
U1 
0 
Case First Shock Second Shock Third Shock Fourth Shock Fifth Shock Sixth Shock 
VT pattern RBBB-LAD(S) RBBB-LAD(S) RBBB-LAD(S) RBBB-LAD (I) LBBB-LAD (I) 
Site of shock(T) Inf-post LV(-60) Inf-post LV( - 70) Inf-post L V( - 85) Inf-post L V( - 80) Inf-post LV( - 120) (lCO ;J>tn 
Chest paddle position Left post-Iat Left post-Iat Left post-Iat Left post -Iat Left post-Iat -Ir :r::r: 
Status after shock NSR (3 mm) NSR (4 h) NSR NSR NSR; frequent VPO, 
tTl;J> 
-ICIl 
tnCll 
;:ootn 
VT pattern 2 RBBB-LAD(I) LBBB-LAD(S) ;J>z 
Site of shock(T) Inf-post LV( - 50) Inf-post LV( - 90) 
cotn 
r-l 
Chest paddle position Left post-Iat Left post-Iat 
;J>;J> 
:jr 
Status after shock NCVT (LBBB-LAD) Transient CA VB 0 Z 
VT pattern 3 LBBB-LAD(I) LBBB-LAD(I) LBBB-LAD (I) 
0 
"r1 
Site of shock(T) Inf-sept-ap LV( -75) Inf-sept-ap LV( -75) Inf-sept-ap LV (- 90) < tn 
Chest paddle position Left post-Iat Left post -Iat V4 
Z 
-I 
;:00 
Status after shock NSR + transient NCVT NSR + frequent VPCs NCVT~DC shock n c: 
VT pattern 4 LBBB-LAD(I) NSR 
r 
;J> 
Site of shock(T) Inf-sept-ap LV( - 200) Inf-sept-ap LV 
;:00 
-I 
Chest paddle position V4 V4 
;J> 
(l 
Status after shock NSR, rare VPCs NSR :r: -< (l 
VT pattern 5 LBBB, NA(I) LBBB, NA(I) LBBB, NA(I) 
;J> 
;:00 
Site of shock(T) Ap-sept LV( -70) Ap-sept L V( - 70) Ap-sept LV( - 70) 0 ;; 
Chest paddle position V4 V4 V4 
Status after shock NSR,LBBB (hours) Transient CA VB NSR 
VT pattern 6 RBBB, aXIS - 150°(1) RBBB, aXI, - 150°(1) RBBB,axis -150°(1) RBBB, RAD(I) 
Site of shock(T) Mid-inf LV( -120) Mid-inf LV( -100) Mid-inf LV( -100) Inf-post-Iat LV ( - 95) 
Chest paddle position Left post-Iat Left post-Iat Left post-I at Left post-Iat 
Status after shock NSR NSR, transient intracardiac NSR NSR, diffuse 
ST depression ischemia, LBBB, 
cardiogenic shock, 
VTIVF~DC shock 
VT pattern 7 LBBB, RAD (S*) LBBB, RAD (S*) LBBB, RAD(S*) LBBB, NA (S) LBBB, NA(S) LBBB, NA(S) 
Site of shock(T) RVOT (-40) RVOT (-40) RVOT (-40) RVS (-40) RVS (-40) RVS (-40) 
Chest paddle position Left post-Iat Left post-Iat Left post-Iat V4 V4 Left post-Iat 
Status after shock NSR, transient RBBB NSR, transient RBBB NSR, transient Transient CA VB Transient CA VB Tran'lent CA VB 
RBBB + LAD, VPCs +LBBB 
VT pattern 8 LBBB, LAD (I) 
Site of shock(T) Mid inf-sept 
Chest paddle position Left post-Iat 
Status after shock NSR, VPCs 
*Ventricular premature complexes having the same configuration as that of ventncular tachycardia. ap = apical; CA VB = complete atnoventricular block; DC = '-'-;J> 
direct current; I = induced by programmed ventricular stimulation; inf = inferior; lat = lateral; LV = left ventricle; NCVT = nonclinical ventricular tachycardia; ~ R 
NSR = normal sinus rhythm; post = posterior; RVOT = right ventncular outflow tract; RVS = right ventricular septum; S = spontaneous; sept = septal; T = time -< 
from endocardial activity to onset of QRS complex at the site of shock(ms); VPC, = ventncular premature complexes; other abbreviations as in Table I. ~2. 
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Figure 1. PatIent I. Endocardial mapping during ventricular 
tachycardia. Electrocardiographic leads I, II, III, V I and intracar-
diac recordings from the right ventricular apex (RV A) and the 
posterobasal area of the left ventncle (L VPB, sites A to E) are 
shown. Before catheter ablation procedures, the earliest endocar-
dial activation is recorded in the posterobasal area of the left 
ventricle 140 ms before the onset of the QRS complex (A). Tech-
nical difficulties prevented delivery of the intracardiac shocks at 
this early site and therefore shocks were delivered at the endo-
cardial sites showing less early activity. Band C represent the 
endocardial sites of activatIOn where a smgle 250 J shock delivered 
during the first ablative procedure resulted in resumptIOn of sinus 
rhythm for 3 minutes and 4 hours, respectively. D and E represent 
the endocardial sites of activation where a single 300 J shock 
delivered during the second ablative procedure abohshed ventric-
ular tachycardia. V = ventricular activity. 
Shock ablation procedures (Table 2). A total of 26 
intracardiac shocks were delivered to the eight patients: two 
patients received 2 shocks, two received 3 shocks and the 
remaining four received 1, 4, 5 or 6 shocks. Of the total of 
26 shocks, 21 were delivered at the site of origin of the 
clinical ventricular tachycardia and 2 at the site of origin of 
nonclinical ventricular tachycardia close to that of the clin-
ical tachycardia, 
Effects of ablative procedures on ventricular tachy-
cardia (Table 3). After the ablative procedures, sponta-
neous ventricular tachycardia did not recur in five patients 
(Cases 1, 2, 4, 5 and 8) during a follow-up period of 17, 
16, 14, 13 and 7 months, respectively, During electro-
physiologic studies performed in four of these patients 7 to 
60 days after the ablative procedures, clinical ventricular 
tachycardia could not be induced by programmed right ven-
tricular stimulation. 
Patient 3 exhibited recurrence of ventricular tachycardia 
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Figure 2. Patient 3. Endocardial mapping during ventricular 
tachycardia. Electrocardiographic leads I, II, III, V I and intracar-
diac electrograms from the right ventricular apex (RV A), atrio-
ventricular junction (A VJ) and the inferoseptal-apical area of the 
left ventricle (LV) are shown. Earliest endocardial activation oc-
curs in the latter area 90 ms before the onset of the QRS complex. 
A = atrial activity; V = ventricular activity. 
Figure 3. Patient 4. Endocardial mapping during ventricular 
tachycardia. The recordings are arranged as in Figure 2; the prox-
imal (P) and distal (D) electrograms from the inferoseptal-apical 
area of the left ventricle (LV) are added, The earliest endocardial 
activation occurs in the proximal electrogram 200 ms before the 
onset of the QRS complex (*). Note that a local 2: 1 exit block 
is present in this area, 
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Table 3. Electrophysiologic Effects of Ablative Procedures In Four Patients 
Before Ablation 
Spontaneous sustained YT 
4 InductIOn of sustained CYT 
with I YPD/CL 500 ms/3 rnA 
5 InductIOn of sustained CYT 
with 2 YPDs/CL 400 m,/20 rnA 
8 Induction of sustained CYT 
with I YPD/CL 600 ms/3 rnA 
After Ablation 
Induction of NCYT (260 beats/min) with 2 
YPDs/CL 600 ms/20 rnA requinng cardloven,lOn 
No induction of YT with 1,2 YPDs/CL 700 to 400 
ms/3 and 20 rnA 
No inductIOn of YT with 1,2 YPDs/CL 700 to 400 
ms/3 and 20 rnA 
Induction of non sustained «6 seconds) pleomorphic 
NCYT with 2 YPDs/CL 700 to 400 ms/3 and 20 
rnA; no induction of CYT 
CL = cycle length; CYT = clinical ventricular tachycardia; NCYT = nonclinical ventricular tachycardia; 
YPD = ventricular premature depolarization; YT = ventricular tachycardia. 
36 hours after the ablative procedure and underwent emer-
gency aneurysmectomy with mapping-guided subendocar-
dial resection of the arrhythmogenic area, The site of origin 
of tachycardia, as demonstrated during surgery, was found 
about 1.5 cm from the zone where three endocardial shocks 
were delivered, Lesions created by the shocks extended over 
an area of organized thrombus and consisted of small craters, 
0.5 cm in diameter, that did not reach the endocardium. 
Ventricular tachycardia could not be induced by ventricular 
stimulation performed 10 days after surgery. Patient 6 de-
veloped severe myocardial ischemia with cardiogenic shock 
and recurrent ventricular tachycardia/ventricular fibrillation 
a few minutes after the second ablative procedure (see later). 
After prolonged resuscitative maneuvers, he recovered, While 
considering coronary revascularization surgery, he died sud-
denly 2 months later, after complaining of chest pains. Non-
sustained ventricular tachycardia «6 complexes) was fre-
quently recorded during transtelephonic electrocardiographic 
monitoring after the ablative procedure, Patient 7 exhibited 
recurrent non sustained ventricular tachycardia after the abla-
tive procedures. However, only the ventricular tachycardia 
presumably originating from the right ventricular outflow 
tract was observed. This arrhythmia was subsequently well 
controlled by flecainide therapy. 
Analysis of the relation of the number of shocks to the 
success of the procedure shows that 75% of the patients 
were successfully treated with three or fewer shocks 
(Fig. 4). 
Immediate complications of ablative procedures. 
Disturbances of cardiac rhythm and conduction were fre-
quently seen immediately after the ablative procedures (Ta-
ble 2). Nonclinical ventricular tachycardia was observed 
after intracardiac shock in two patients (Cases 2 and 3) and 
required cardioversion in one. Intraventricular and atrio-
ventricular conduction disturbances were noted in four pa-
tients (Cases 2, 5, 6 and 7); in three, these disturbances 
were transient, disappearing within minutes to days, but in 
one patient (Case 6), left bundle branch block persisted. 
Severe hemodynamic deterioration was noted in one pa-
tient (Case 6). Three days after uncomplicated administra-
tion of a series of three intracardiac shocks to ablate one 
configurational type of clinical ventricular tachycardia, an 
attempt was made to ablate a second configurational type. 
A single 300 J shock was given during well tolerated ven-
tricular tachycardia of 10 minutes' duration. On restoration 
of sinus rhythm, diffuse and marked ST-T wave changes 
appeared and the patient rapidly developed severe cardio-
genic shock with recurrent episodes of ventricular fibrilla-
tion requiring mUltiple external cardioversions. After a pro-
Figure 4. Relation of the number of shocks to the success of the 
ablative procedure. The abscissa indicates the number of shocks 
delivered and the ordinate indicates the cumulative proportion of 
patients who successfully responded after that number of shocks, 
Q) 
~ .. 
(n) # observatIons 
] (8,..)_~ 
" u 
(1) 
O~---1----'----''---'----''---, 
o 2 3 4 5 6 
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longed resuscitative procedure, including administration of 
high doses of inotropic agents, the patient recovered without 
evident cardiac or neurologic impairment. 
In one patient (Case 2), a marked but brief «2 minutes) 
subendocardial injury pattern was recorded on the intracar-
diac electrogram close to the site where the shock was de-
livered, This was not associated with any significant ST -T 
wave changes on the surface electrocardiographic leads. 
Clinical and electrocardiographic course. In Patients 
1 and 7, a pericardial rub heard the day after delivery of 
the shocks disappeared within a few days. Patient I devel-
oped two episodes of left heart failure 3 days after the 
ablative procedure; both episodes promptly responded to 
intravenous administration of furosemide. During the fol-
low-up period, the patient gave a history of two episodes 
of paroxysmal nocturnal dyspnea, The occurrence of 
congestive heart failure after the ablative procedure con-
trasted with its absence during a 3 day period of incessant 
ventricular tachycardia before the shocks. In the remaining 
patients, there were no significant clinical or electrocardio-
graphic changes, 
Assessment of myocardial damage. The left ventric-
ular ejection fraction, as measured by radionuclide ventric-
ulography before and after the ablative procedure in seven 
patients, significantly decreased in two patients (from 26 to 
20% in Patient 2 and from 19 to 12% in Patient 4). In the 
remaining five patients, the left ventricular ejection fraction 
remained unchanged (33 ± 8% before and after ablative 
procedures). New development of left ventricular contrac-
tion abnormalities was observed in only one patient (Case 
2), who also exhibited permanent left bundle branch block 
after the ablative procedure. The peak serum creatine kinase 
level after the ablative procedure ranged from 60 to 1,000 
IU with MB fraction ranging from 3.4 to 8,7%, 
Discussion 
An important innovation in the management of patients 
with drug-refractory cardiac arrhythmias has been the ability 
to ablate these arrhythmias, or the sites critical to their 
maintenance, by endocardial shocks delivered through elec-
trode catheters. These procedures have been extensively and 
successfully used for ablating the atrioventricular (A V) junc-
tion to control a rapid ventricular response during atrial 
tachyarrhythmias or drug-refractory A V reentrant tachycar-
dias (14-16), In contrast, experience with the use of these 
procedures to ablate ventricular tachycardia is limited. To 
date there have been only a few studies, most of them 
including a small number of patients (4-11). 
Previous reports on catheter ablation of ventricular 
tachycardia. Hartzler (4) was the first to report catheter 
ablation of ventricular tachycardia in three patients, Ven-
tricular tachycardia originated in the right ventricular out-
flow tract in one patient with no organic heart disease and 
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in the left ventricular septum in two patients with previous 
myocardial infarction, After the ablative procedure, ven-
tricular tachycardia did not recur during a 12 month follow-
up period in the patient without organic heart disease, In 
one of the patients with coronary heart disease, ventricular 
tachycardia was no longer inducible during electrophysio-
logic study and did not recur for 5 months, In the remaining 
patient, clinical ventricular tachycardia did not recur for 3 
months before the patient's death from low output conges-
tive heart failure. Puech et aL (6) described a patient with 
arrhythmogenic right ventricular dysplasia in whom a single 
endocardial shock prevented ventricular tachycardia during 
a 12 month follow-up period, More recently, Ruffy et aL 
(10) described successful ablation of a fascicular ventricular 
tachycardia in a patient with previous myocardial infarction, 
Of the 16 patients who underwent catheter ablation of ven-
tricular tachycardia and were reported on in abstract form 
(7-9), six did not exhibit recurrence of ventricular tachy-
cardia during a follow-up period of up to 12 months. 
Results of the present study. In the present study, we 
attempted transcatheter shock ablation of ventricular tachy-
cardia in eight patients. In seven of the eight, the tachycardia 
was drug-resistant and even refractory to repeated external 
cardioversions in one patient. In the remaining patient, spon-
taneous ventricular tachycardia did not recur during antiar-
rhythmic drug therapy, but catheter ablation of ventricular 
tachycardia was attempted because no antiarrhythmic drug 
prevented induction of sustained rapid ventricular tachy-
cardia by programmed ventricular stimulation. 
Catheter ablative procedures prevented spontaneous oc-
currence of ventricular tachycardia in five of our eight pa-
tients during a follow-up period ranging from 7 to 17 months, 
The most dramatic results were observed in Patient 1, who 
had incessant ventricular tachycardia refractory to repeated 
external cardioversions before the ablative procedure (11), 
In addition, in all four patients who underwent electro-
physiologic studies after the ablative procedure, pro-
grammed ventricular stimulation failed to induce the clinical 
ventricular tachycardia, suggesting a definite cure of the 
arrhythmia. Interestingly, four of the five patients in whom 
the ablative procedure succeeded were high risk surgical 
candidates: one patient (Case I) had a 3 week old myocardial 
infarction and ventricular tachycardia originating in the in-
ferior wall (17); the three remaining patients had a previous 
myocardial infarction and severe ventricular dysfunction. 
Therefore, catheter ablation of ventricular tachycardia ap-
pears to represent a promising method of treatment in pa-
tients with ventricular tachycardia who are high risk can-
didates for surgery. 
Factors affecting success in ablative procedures. 
Considering that catheter endocardial mapping allows lo-
calization of the origin of ventricular tachycardia with an 
accuracy of approximately 4 cm2 (12), it can be assumed 
that the success of ablative procedures and the number of 
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shocks required to ablate the arrhythmia are highly depen-
dent on the adequate localization of the tachycardia and on 
administering the shock at the area that demonstrates the 
earliest activation. This assumption is supported by the fol-
lowing observations in three of our patients: in Patients 4 
and 8 a very early endocardial activation during ventricular 
tachycardia was found (200 and 100 ms, respectively, before 
the onset of the QRS complex) (Fig. 3) and a single intra-
cardiac shock was successful. However, in Patient I, tech-
nical difficulties prevented delivery of shocks at the site 
showing the earliest endocardial activation during ventric-
ular tachycardia (140 ms before the onset of the QRS com-
plex). In this patient, four shocks were given close to the 
site of origin of the tachycardia (at the earliest endocardial 
activation of 60 to 85 ms before onset of the QRS complex) 
and the multiple shocks were apparently necessary to ablate 
the tachycardia. 
Complications. The incidence of reported complica-
tions after catheter ablation of ventricular tachycardia has 
been variable. In a study of four patients, Hartzler and 
Giorgi (5) noted transient "inus bradycardia, right bundle 
branch block and spontaneously terminating ventricular fi-
brillation. No complications were reported by Puech et al. 
(6) and Downar et al. (9) in one and four patients, respec-
tively. Steinhaus et al. (7) did not observe any major com-
plication or demonstrable change in left ventricular function 
in six patients. Winston et al. (8) reported transient aphasia 
in one of their six patients. Ruffy et al. (10) noted a life-
threatening new form of ventricular tachycardia in one pa-
tient during the first 24 hours after the ablative procedure. 
In the present study we observed a high incidence of com-
plications that appeared to be directly related to the ablative 
procedure. Transient electrical instability, as manifested by 
nonclinical ventricular tachycardia, occurred in two pa-
tients. This has been frequently observed in dogs after en-
docardial ablation (18-20). Atrioventricular and intraven-
tricular conduction disturbances were noted in four patients 
but were transient in three of the four. The most disturbing 
complication was the hemodynamic impairment observed 
in three patients: left-sided heart failure (one patient), and 
a significant decrease in left ventricular ejection fraction 
(two patients) with development of ventricular contraction 
abnormalities in one patient. In the normal canine ventricle, 
two discharges of 200 J have been shown to produce en-
docardial necrosis 9 mm in depth and 18 mm in breadth 
(20). Although endocardial lesions caused by shocks may 
be different in normal canine and scarred human ventricles, 
our results suggest that a substantial area of myocardial 
necrosis is created by multiple shocks of 300 J in the human 
ventricle. 
Although developing immediately after the ablative pro-
cedure, the cardiogenic shock in Patient 6 was probably not 
related to the shock itself, but rather to myocardial ischemia 
caused by prolonged endocardial mapping of ventricular 
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tachycardia. Indeed, this patient had previously had several 
episodes of prolonged hypotension that occurred after isch-
emic episodes that were not associated with ventricular 
tachycardia. 
Conclusions. Our preliminary experience suggests that 
transcatheter shock ablation of ventricular tachycardia rep-
resents an important innovation in the management of pa-
tients with drug-refractory ventricular tachycardia. This pro-
cedure may be an alternative to antitachycardia surgery in 
high risk candidates for surgery. However, the high inci-
dence of complications observed should temper any temp-
tation to consider routine use of this procedure in patients 
with ventricular tachycardia. Because only limited experi-
ence has been reported so far, we recommend that only 
those patients with recurrent, sustained ventricular tachy-
cardia refractory to antiarrhythmic drugs should be consid-
ered for this procedure. Extreme caution should prevail in 
patients with severely impaired left ventricular function. 
Future efforts should be directed to other modes of ablation, 
such as laser ablation, which creates controlled endocardial 
lesions with less energy and produces less deleterious effects 
than those produced by transcatheter electrode shock (19). 
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